Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $477.23 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $125.00 | 1 | $0 (2018) |
| Davol Inc. | $93.66 | 5 | $0 (2024) |
| PFIZER INC. | $61.16 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $39.43 | 3 | $0 (2023) |
| Novo Nordisk Inc | $38.54 | 3 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.47 | 1 | $0 (2023) |
| Dynavax Technologies Corporation | $18.70 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $17.67 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $16.68 | 1 | $0 (2020) |
| Lundbeck LLC | $15.98 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.44 | 2 | Davol Inc. ($15.00) |
| 2023 | $133.11 | 8 | PFIZER INC. ($34.17) |
| 2022 | $30.28 | 1 | Davol Inc. ($30.28) |
| 2021 | $53.03 | 3 | Davol Inc. ($20.71) |
| 2020 | $69.37 | 5 | Novo Nordisk Inc ($25.64) |
| 2019 | $24.45 | 2 | Novo Nordisk Inc ($12.90) |
| 2018 | $137.55 | 2 | Neurocrine Biosciences, Inc. ($125.00) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/09/2024 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Surgery | ||||||
| 01/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: PAIN | ||||||
| 12/05/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: PSYCHIATRY | ||||||
| 11/29/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: DIABETES | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Respiratory | ||||||
| 09/19/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: PAIN | ||||||
| 09/07/2023 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Surgery | ||||||
| 07/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 04/11/2023 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Hepatitis B Vaccine | ||||||
| 07/14/2022 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: BD Interventional Surgery | ||||||
| 08/14/2021 | Davol Inc. | Phasix (Device) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: BD Interventional Surgery | ||||||
| 07/15/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, VERQUVO | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/31/2020 | Davol Inc. | Phasix (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Davol | ||||||
| 02/10/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Respiratory | ||||||
| 02/06/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Cardiovascular | ||||||
| 01/22/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Obesity | ||||||
| 01/14/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 12/06/2019 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 07/16/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROLOGY | ||||||
| 04/27/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 487 | 615 | $19,385 | $3,559 |
| 2022 | 1 | 142 | 156 | $4,836 | $1,011 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 471 | 599 | $18,569 | $3,345 | 18.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 16 | 16 | $816.00 | $213.90 | 26.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 142 | 156 | $4,836 | $1,011 | 20.9% |
About Dr. Elisabeth Cardwell, M.D
Dr. Elisabeth Cardwell, M.D is a Internal Medicine healthcare provider based in Woodstock, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437158631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elisabeth Cardwell, M.D has received a total of $477.23 in payments from pharmaceutical and medical device companies, with $29.44 received in 2024. These payments were reported across 23 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($477.23).
As a Medicare-enrolled provider, Cardwell has provided services to 629 Medicare beneficiaries, totaling 771 services with total Medicare billing of $4,570. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Woodstock, VA
- Active Since 07/19/2005
- Last Updated 02/27/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437158631
Products in Payments
- INGREZZA (Drug) $125.00
- Phasix Mesh (Device) $58.42
- Phasix (Device) $35.24
- ELIQUIS (Drug) $33.47
- NURTEC ODT (Drug) $31.82
- JARDIANCE (Drug) $21.47
- Heplisav-B (Drug) $18.70
- BELSOMRA (Drug) $17.67
- REXULTI (Drug) $15.98
- BREZTRI (Drug) $15.36
- XARELTO (Drug) $14.65
- MOUNJARO (Drug) $14.29
- Ozempic (Drug) $14.15
- Xultophy 100/3.6 (Drug) $12.90
- CHANTIX (Drug) $12.55
- SYMBICORT (Drug) $12.52
- FARXIGA (Drug) $11.55
- Saxenda (Drug) $11.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.